Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Common Stock Shares Outstanding of 61.75 million shares for the year ending 2023.
- TREACE MEDICAL CONCEPTS, INC. showed an increase of +11.0% in Common Stock Shares Outstanding from 2022 to 2023.
- This data is from TREACE MEDICAL CONCEPTS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2024.
- XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: 55.28 million shares | Q2 2022: 55.39 million shares | Q3 2022: 55.50 million shares | Q1 2023: 61.28 million shares | Q2 2023: 61.53 million shares | Q3 2023: 61.61 million shares | Q4 2023: 61.75 million shares | Q1 2024: 61.93 million shares | Q2 2024: 62.18 million shares | Q3 2024: 62.28 million shares.
- Over the full 3 years of available data (2021 to 2023), TREACE MEDICAL CONCEPTS, INC.'s Common Stock Shares Outstanding has grown by 14.0%.
- Historical annual values: Fiscal year 2023: 61.75 million shares | Fiscal year 2022: 55.63 million shares | Fiscal year 2021: 54.18 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: